The Gastroenterology Group, PC, Announces Expansion into Clinical Research
Reston, Va., Feb. 20, 2018 (Business Wire)-The Gastroenterology Group, PC, a gastroenterology practice based in Reston, Va., announces its expansion into clinical research by partnering with Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients.
The Gastroenterology Group is now offering clinical trials, allowing it to introduce the latest advances in research to its patients. As a result, the clinic’s patients have access - in the convenience of the clinic’s office - to treatments they might not otherwise have. The Gastroenterology Group recognizes the importance of conducting clinical research for its patients and community and doing its part to advance health care around the world.
“As a practice on the forefront of medicine, we are pleased to be able to offer clinical trials as treatment options for our patients. This will give our patients access to novel therapies that they would otherwise not have,” said Emil E. Valle, M.D., of The Gastroenterology Group. “Expanding treatment options for conditions, such as inflammatory bowel disease, is extremely important to provide optimal care. It was Elligo’s unique approach of providing clinical trial infrastructure at no cost that made offering trials feasible. We look forward to being a part of the Elligo network.”
“Elligo is delighted to be working with The Gastroenterology Group to advance the care its physicians are offering to patients,” said John Potthoff, Ph.D., co-founder and CEO of Elligo Health Research. “We provide the personnel, processes, technology and infrastructure to make the clinical research process easier for clinics at no cost, so they can focus on taking care of patients.”
About The Gastroenterology Group, PC
At The Gastroenterology Group, we believe that each patient and doctor becomes a team for treating an individual's digestive problems. Our gastroenterologists spend most of their time listening to understand your concerns and to respond with the best treatment options for you. Our professional staff understands the importance of following up to make sure that problems are resolved and your health improves.
CONTACT:
Lea Studer
SCORR Marketing
402-366-1752
lea@scorrmarketing.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
